BloodWorks ApS: Financial statements 2025
CVR: 43248669
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
BloodWorks ApS (CVR 43248669) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -919,617 and a net result of DKK -2,489,113 compared with DKK -2,028,937 the year before. Equity in the 2025 report amounted to DKK -6,460,405. The company had 1 employee in the financial year.
- Gross Profit
- DKK -919,617
- Profit/Loss
- DKK -2,489,113
- Equity
- DKK -6,460,405
- Total Assets
- DKK 14,562,238
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -920 t. | -2.5 mio. | -6.5 mio. | 1 |
| 2024 | - | -359 t. | -2 mio. | -4 mio. | 1 |
Official annual report
How creditworthy is BloodWorks ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BloodWorks ApS
BloodWorks ApS is a Danish company of the type Anpartsselskab based in Åbyhøj, founded in 2022. The company is registered under the industry Speciallægers aktiviteter. The management consists of Thomas Bach Urban. The company is owned by SPECIALTANDLÆGE THOMAS BACH URBAN ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -919,617 and a net result of DKK -2,489,113 compared with DKK -2,028,937 the year before. Equity in the 2025 report amounted to DKK -6,460,405.